Home > Maligne hematologie > Lymfoïde ziekten > Plasmaceldyscrasieën > Multipel myeloom > Trispecific Antibody (79635322MMY1001)

Trispecific Antibody (79635322MMY1001)

Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 22-12-2024, 4:07